{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:10:03Z","timestamp":1790554203266,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25MH119857"],"award-info":[{"award-number":["R25MH119857"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harvard Center for AIDS Research","award":["5P30AI060354"],"award-info":[{"award-number":["5P30AI060354"]}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10461-025-04876-8","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T23:44:42Z","timestamp":1759103082000},"page":"403-417","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Strategies to Improve PrEP Adherence in People Who Use Drugs: A Systematic Review"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6750-2598","authenticated-orcid":false,"given":"Janae","family":"Briggs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6928-7482","authenticated-orcid":false,"given":"John","family":"Chiosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisha","family":"Papineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0443-1986","authenticated-orcid":false,"given":"Megan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"4876_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12954-022-00721-6","volume":"19","author":"TS Bartholomew","year":"2022","unstructured":"Bartholomew TS, Andraka-Cristou B, Totaram RK, Harris S, Doblecki-Lewis S, Ostrer L, Serota DP, Forrest DW, Chueng TA, Suarez E, Tookes HE. We want everything in a one-stop shop: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for black people who inject drugs. Harm Reduct J. 2022;19:133. https:\/\/doi.org\/10.1186\/s12954-022-00721-6.","journal-title":"Harm Reduct J"},{"key":"4876_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-020-02988-x","author":"CB Mistler","year":"2020","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure prophylaxis (PrEP) care cascade in people who inject drugs: a systematic review. AIDS Behav. 2020. https:\/\/doi.org\/10.1007\/s10461-020-02988-x.","journal-title":"AIDS Behav"},{"key":"4876_CR3","unstructured":"World Health Organization. People who inject drugs. In: Global HIV, Hepatitis and STIs Programmes. https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/populations\/people-who-inject-drugs. Accessed 2 Mar 2023."},{"key":"4876_CR4","unstructured":"Understanding the Impact of Data: HIV Diagnoses, Incidence, and Prevalence. https:\/\/www.cdc.gov\/hiv-data\/about\/impact.html."},{"key":"4876_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S0140-6736(10)61005-7","volume":"376","author":"C Beyrer","year":"2010","unstructured":"Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Strathdee SA. 12 myths about HIV\/AIDS and people who use drugs. The Lancet. 2010;376:208\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(10)61005-7.","journal-title":"Lancet"},{"key":"4876_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0140-6736(10)61026-4","volume":"376","author":"N El-Bassel","year":"2010","unstructured":"El-Bassel N, Terlikbaeva A, Pinkham S. HIV and women who use drugs: double neglect, double risk. The Lancet. 2010;376:312\u20134. https:\/\/doi.org\/10.1016\/S0140-6736(10)61026-4.","journal-title":"Lancet"},{"key":"4876_CR7","doi-asserted-by":"publisher","first-page":"1265063","DOI":"10.3389\/fpubh.2023.1265063","volume":"11","author":"T Dzinamarira","year":"2023","unstructured":"Dzinamarira T, Moyo E. The use of oral HIV pre-exposure prophylaxis among people who inject drugs: barriers, and recommendations. Front Public Health. 2023;11:1265063. https:\/\/doi.org\/10.3389\/fpubh.2023.1265063.","journal-title":"Front Public Health"},{"key":"4876_CR8","unstructured":"Centers for Disease Control and Prevention. Injection drug use. 2022. https:\/\/www.cdc.gov\/hiv\/risk\/drugs\/index.html. Accessed 13 Feb 2023."},{"key":"4876_CR9","doi-asserted-by":"publisher","first-page":"109540","DOI":"10.1016\/j.drugalcdep.2022.109540","volume":"237","author":"MP Montgomery","year":"2022","unstructured":"Montgomery MP, Zhong Y, Roberts E, Asher A, Bixler D, Doshani M, Christensen A, Eckert M, Weng MK, Carry M, Samuel CR, Teshale EH. Vaccination barriers and opportunities at syringe services programs in the United States, June\u2013August 2021\u2014a cross-sectional survey. Drug Alcohol Depend. 2022;237:109540. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109540.","journal-title":"Drug Alcohol Depend"},{"key":"4876_CR10","doi-asserted-by":"publisher","first-page":"104382","DOI":"10.1016\/j.drugpo.2024.104382","volume":"127","author":"O Price","year":"2024","unstructured":"Price O, Swanton R, Grebely J, Hajarizadeh B, Webb P, Peacock A, Dore GJ, Cowie BC, Vickerman P, Degenhardt L. Vaccination coverage among people who inject drugs: a systematic review. Int J Drug Policy. 2024;127:104382. https:\/\/doi.org\/10.1016\/j.drugpo.2024.104382.","journal-title":"Int J Drug Policy"},{"key":"4876_CR11","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1007\/s10461-018-2099-0","volume":"22","author":"R Shrestha","year":"2018","unstructured":"Shrestha R, Altice FL, Karki P, Copenhaver MM. Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: a pilot feasibility study. AIDS Behav. 2018;22:2640. https:\/\/doi.org\/10.1007\/s10461-018-2099-0.","journal-title":"AIDS Behav"},{"key":"4876_CR12","unstructured":"CDC. Preventing HIV with PrEP. In: HIV. 2024. https:\/\/www.cdc.gov\/hiv\/prevention\/prep.html. Accessed 24 Jan 2025."},{"key":"4876_CR13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/PPA.S236794","volume":"14","author":"R Shrestha","year":"2020","unstructured":"Shrestha R, Altice FL, DiDomizio E, Sibilio B, Ranjit YS, Copenhaver MM. Feasibility and acceptability of an mHealth-based approach as an HIV prevention strategy among people who use drugs on pre-exposure prophylaxis. Patient Prefer Adherence. 2020;14:107. https:\/\/doi.org\/10.2147\/PPA.S236794.","journal-title":"Patient Prefer Adherence"},{"key":"4876_CR14","unstructured":"Centers for Disease Control and Prevention. Pre-exposure prophylaxis (PrEP) | HIV risk and prevention | HIV\/AIDS | CDC. 2023. https:\/\/www.cdc.gov\/hiv\/risk\/prep\/index.html. Accessed 13 Feb 2023."},{"key":"4876_CR15","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","volume":"381","author":"K Choopanya","year":"2013","unstructured":"Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, Chiamwongpaet S, Kitisin P, Natrujirote P, Kittimunkong S, Chuachoowong R, Gvetadze RJ, McNicholl JM, Paxton LA, Curlin ME, Hendrix CW, Vanichseni S. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. The Lancet. 2013;381:2083\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(13)61127-7.","journal-title":"Lancet"},{"key":"4876_CR16","doi-asserted-by":"publisher","first-page":"108477","DOI":"10.1016\/j.drugalcdep.2020.108477","volume":"219","author":"Z Ni","year":"2021","unstructured":"Ni Z, Altice FL, Wickersham JA, Copenhaver MM, DiDomizio EE, Nelson LE, Shrestha R. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment. Drug Alcohol Depend. 2021;219:108477. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108477.","journal-title":"Drug Alcohol Depend"},{"key":"4876_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/157016212799304689","volume":"10","author":"DM Tebit","year":"2012","unstructured":"Tebit DM, Ndembi N, Weinberg A, Qui\u00f1ones-Mateu ME. Mucosal transmission of human immunodeficiency virus. Curr HIV Res. 2012;10:3\u20138. https:\/\/doi.org\/10.2174\/157016212799304689.","journal-title":"Curr HIV Res"},{"key":"4876_CR18","volume-title":"Preexposure prophylaxis for HIV prevention","author":"V Sundareshan","year":"2024","unstructured":"Sundareshan V, Swinkels HM, Nguyen AD, Mangat R, Koirala J. Preexposure prophylaxis for HIV prevention. In: StatPearls. Treasure Island: StatPearls Publishing; 2024."},{"key":"4876_CR19","unstructured":"Centers for Disease Control and Prevention. Preventing HIV with PrEP. In: HIV. 2024. https:\/\/www.cdc.gov\/hiv\/prevention\/prep.html. Accessed 26 June 2025."},{"key":"4876_CR20","doi-asserted-by":"publisher","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","volume":"3","author":"KB Patterson","year":"2011","unstructured":"Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, Cohen MS, Kashuba ADM. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3:112re4. https:\/\/doi.org\/10.1126\/scitranslmed.3003174.","journal-title":"Sci Transl Med"},{"key":"4876_CR21","doi-asserted-by":"publisher","first-page":"e048478","DOI":"10.1136\/bmjopen-2020-048478","volume":"12","author":"EO Murchu","year":"2022","unstructured":"Murchu EO, Marshall L, Teljeur C, Harrington P, Hayes C, Moran P, Ryan M. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations. BMJ Open. 2022;12:e048478. https:\/\/doi.org\/10.1136\/bmjopen-2020-048478.","journal-title":"BMJ Open"},{"key":"4876_CR22","doi-asserted-by":"publisher","first-page":"S517","DOI":"10.1093\/ofid\/ofaa439.1165","volume":"7","author":"S Hebel","year":"2020","unstructured":"Hebel S, Kahn-Woods E, Enghuus C, Koenig H, Lalley-Chareczko L, Radix A, Daughtridge G. 979. Disparities in PrEP uptake and adherence among cisgender women using a pharmacologic measure. Open Forum Infect Dis. 2020;7:S517\u20138. https:\/\/doi.org\/10.1093\/ofid\/ofaa439.1165.","journal-title":"Open Forum Infect Dis"},{"key":"4876_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jadohealth.2021.04.001","volume":"70","author":"BA Allison","year":"2022","unstructured":"Allison BA, Widman L, Stewart JL, Evans R, Perry M. Adherence to pre-exposure prophylaxis in adolescents and young adults: a systematic review and meta-analysis. J Adolesc Health. 2022;70:28\u201341. https:\/\/doi.org\/10.1016\/j.jadohealth.2021.04.001.","journal-title":"J Adolesc Health"},{"key":"4876_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/QAI.0000000000002915","volume":"90","author":"L Starbuck","year":"2022","unstructured":"Starbuck L, Golub SA, Klein A, Harris AB, Guerra A, Rincon C, Radix AE. Transgender women and PrEP care: high PrEP adherence in a real-world health care setting in New York City. J Acquir Immune Defic Syndr. 2022;90:15\u20139. https:\/\/doi.org\/10.1097\/QAI.0000000000002915.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4876_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10461-022-03826-y","volume":"27","author":"A Townes","year":"2022","unstructured":"Townes A, Pyra M, Smith DK, Babu AS, Williams T, Wiener J, Henny KD, Schneider J. PrEP use and adherence among transgender persons in Chicago, IL (SHIPP Study, 2014\u20132018, USA). AIDS Behav. 2022;27:901\u20138. https:\/\/doi.org\/10.1007\/s10461-022-03826-y.","journal-title":"AIDS Behav"},{"key":"4876_CR26","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1080\/08897077.2019.1706695","volume":"42","author":"N Sohler","year":"2021","unstructured":"Sohler N, Slawek D, Earnshaw V, Jost J, Lee A, Mancini J, Mompremier A, Cunningham C. Drug use and HIV medication adherence in people living with HIV. Subst Abus. 2021;42:310\u20136. https:\/\/doi.org\/10.1080\/08897077.2019.1706695.","journal-title":"Subst Abus"},{"key":"4876_CR27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11904-012-0134-8","volume":"9","author":"M CampBinford","year":"2012","unstructured":"CampBinford M, Kahana SY, Altice FL. A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs. Curr HIV\/AIDS Rep. 2012;9:287\u2013312. https:\/\/doi.org\/10.1007\/s11904-012-0134-8.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"4876_CR28","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1186\/s12889-023-17113-5","volume":"23","author":"EV Pitpitan","year":"2023","unstructured":"Pitpitan EV, Wiginton JM, Bejarano-Romero R, Baker DA. Promoting HIV care continuum outcomes among people who use drugs and alcohol: a systematic review of randomized trials evaluating behavioral HIV care interventions published from 2011 to 2023. BMC Public Health. 2023;23:2182. https:\/\/doi.org\/10.1186\/s12889-023-17113-5.","journal-title":"BMC Public Health"},{"key":"4876_CR29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11908-018-0636-7","volume":"20","author":"ME Soc\u00edas","year":"2018","unstructured":"Soc\u00edas ME, Milloy M-J. Substance use and adherence to antiretroviral therapy: what is known, and what is unknown. Curr Infect Dis Rep. 2018;20:36. https:\/\/doi.org\/10.1007\/s11908-018-0636-7.","journal-title":"Curr Infect Dis Rep"},{"key":"4876_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s11904-018-0385-0","volume":"15","author":"SA Golub","year":"2018","unstructured":"Golub SA. PrEP stigma: implicit and explicit drivers of disparity. Curr HIV\/AIDS Rep. 2018;15:190. https:\/\/doi.org\/10.1007\/s11904-018-0385-0.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"4876_CR31","doi-asserted-by":"publisher","unstructured":"Gilbert HN, Wyatt MA, Pisarski EE, Muwonge TR, Heffron R, Katabira ET, Celum CL, Baeten JM, Haberer JE, Ware NC. PrEP discontinuation and prevention-effective adherence: experiences of PrEP users in Ugandan HIV serodiscordant couples. J Acquir Immune Defic Syndr (1999). 2019;82:265. https:\/\/doi.org\/10.1097\/QAI.0000000000002139","DOI":"10.1097\/QAI.0000000000002139"},{"key":"4876_CR32","doi-asserted-by":"publisher","unstructured":"Hoenigl M, Hassan A, Moore DJ, Anderson PL, Corado K, Dub\u00e9 MP, Ellorin EE, Blumenthal J, Morris SR, Team CCTG (CCTG) 601. Predictors of long term HIV pre exposure prophylaxis adherence after study participation in men who have sex with men. J Acquir Immune Defic Syndr. 2019;81:166. https:\/\/doi.org\/10.1097\/QAI.0000000000002003.","DOI":"10.1097\/QAI.0000000000002003"},{"key":"4876_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","volume":"14","author":"RM Grant","year":"2014","unstructured":"Grant RM, Anderson PL, McMahan V, Liu A, Amico KR, Mehrotra M, Hosek S, Mosquera C, Casapia M, Montoya O, Buchbinder S, Veloso VG, Mayer K, Chariyalertsak S, Bekker L-G, Kallas EG, Schechter M, Guanira J, Bushman L, Burns DN, Rooney JF, Glidden DV, Team for the iPrEx study. An observational study of preexposure prophylaxis uptake, sexual practices, and HIV incidence among men and transgender women who have sex with men. Lancet Infect Dis. 2014;14:820. https:\/\/doi.org\/10.1016\/S1473-3099(14)70847-3.","journal-title":"Lancet Infect Dis"},{"key":"4876_CR34","doi-asserted-by":"publisher","unstructured":"Chai PR, Mohamed Y, Bustamante MJ, Goodman GR, Najarro J, Castillo-Mancilla J, Baez A, Bronzi O, Sullivan MC, Pereira LM, Baumgartner SL, Carnes TC, Mayer KH, Rosen RK, Boyer EW, O\u2019Cleirigh C. DigiPrEP: a pilot trial to evaluate the feasibility, acceptability, and accuracy of a digital pill system to measure PrEP adherence in men who have sex with men who use substances. J Acquir Immune Defic Syndr (1999). 2021;89:e5. https:\/\/doi.org\/10.1097\/QAI.0000000000002854","DOI":"10.1097\/QAI.0000000000002854"},{"key":"4876_CR35","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/cpt.1201","volume":"104","author":"KM Brooks","year":"2018","unstructured":"Brooks KM, Anderson PL. Pharmacologic-based methods of adherence assessment in HIV prevention. Clin Pharmacol Ther. 2018;104:1056. https:\/\/doi.org\/10.1002\/cpt.1201.","journal-title":"Clin Pharmacol Ther"},{"key":"4876_CR36","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, Tugwell P. Ottawa Hospital Research Institute. In: The Ottowa Hospital. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 29 May 2025."},{"key":"4876_CR37","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovi\u0107 J, Schulz KF, Weeks L, Sterne JAC. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928.","journal-title":"BMJ"},{"key":"4876_CR38","doi-asserted-by":"publisher","first-page":"204993612210914","DOI":"10.1177\/20499361221091418","volume":"9","author":"M Haines","year":"2022","unstructured":"Haines M, O\u2019Byrne P. Nurse-led safer opioid supply and HIV pre-exposure prophylaxis: a novel pilot project. Ther Adv Infect Dis. 2022;9:20499361221091418. https:\/\/doi.org\/10.1177\/20499361221091418.","journal-title":"Therapeutic Adv Infect Disease"},{"key":"4876_CR39","doi-asserted-by":"publisher","unstructured":"Roth AM, Tran NK, Felsher MA, Gadegbeku AB, Piecara B, Fox R, Krakower DS, Bellamy SL, Amico KR, Benitez JA, Pol BVD. Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: results from the Project SHE demonstration study. J Acquir Immune Defic Syndr (1999). 2021;86:e61. https:\/\/doi.org\/10.1097\/QAI.0000000000002558","DOI":"10.1097\/QAI.0000000000002558"},{"key":"4876_CR40","doi-asserted-by":"publisher","first-page":"ofab658","DOI":"10.1093\/ofid\/ofab658","volume":"9","author":"C Brokus","year":"2021","unstructured":"Brokus C, Kattakuzhy S, Gayle B, Narayanan S, Davis A, Cover A, Eyasu R, Ebah E, Ogbumbadiugha-Weekes O, Hoffmann J, Silk R, Stevens J, Mount J, Gannon C, Nussdorf L, Mathur P, Bijole P, Jones M, Kier R, Sternberg D, Greenblatt A, Weintraub E, Masur H, Kottilil S, Rosenthal E. Suboptimal uptake, retention, and adherence of daily oral prexposure prophylaxis among people with opioid use disorder receiving hepatitis C virus treatment. Open Forum Infect Dis. 2021;9:ofab658. https:\/\/doi.org\/10.1093\/ofid\/ofab658.","journal-title":"Open Forum Infect Dis"},{"key":"4876_CR41","unstructured":"McKellar M, Des Marais AC, Chen H, Choi Y, Lilly R, Ayers D, Jesse B, Kestner L, Perry B, Poley S, Corneli A, Meade CS, Sachdeva N. Providing comprehensive harm reduction via telemedicine for PWID using syringe services programs: a feasibility study. Clinicaltrials.gov. 2023."},{"key":"4876_CR42","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/hiv.13181","volume":"22","author":"C Grimshaw","year":"2021","unstructured":"Grimshaw C, Boyd L, Smith M, Estcourt CS, Metcalfe R. Evaluation of an inner city HIV pre-exposure prophylaxis service tailored to the needs of people who inject drugs. HIV Med. 2021;22:965\u201370. https:\/\/doi.org\/10.1111\/hiv.13181.","journal-title":"HIV Med"},{"key":"4876_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1080\/10826084.2023.2165409","volume":"58","author":"VB Serrano","year":"2023","unstructured":"Serrano VB, Moore DJ, Morris S, Tang B, Liao A, Hoenigl M, Montoya JL. Efficacy of daily text messaging to support adherence to HIV pre-exposure prophylaxis (PrEP) among stimulant-using men who have sex with men. Subst Use Misuse. 2023;58:465\u20139. https:\/\/doi.org\/10.1080\/10826084.2023.2165409.","journal-title":"Subst Use Misuse"},{"key":"4876_CR44","unstructured":"Centers for Medicare & Medicaid Services. Pharmaceutical manufacturer patient assistance program information. 2023. https:\/\/www.cms.gov\/medicare\/coverage\/prescription-drug-coverage\/patient-assistance-program. Accessed 5 Aug 2024."},{"key":"4876_CR45","unstructured":"Substance Abuse and Mental Health Services Administration. Addressing the specific needs of women for treatment of substance use disorders. https:\/\/library.samhsa.gov\/sites\/default\/files\/pep20-06-04-002.pdf."},{"key":"4876_CR46","doi-asserted-by":"publisher","first-page":"108218","DOI":"10.1016\/j.drugalcdep.2020.108218","volume":"215","author":"JL Glick","year":"2020","unstructured":"Glick JL, Huang A, Russo R, Jivapong B, Ramasamy V, Rosman L, Pelaez D, Footer KH, Sherman SG. ART uptake and adherence among women who use drugs globally: a scoping review. Drug Alcohol Depend. 2020;215:108218. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108218.","journal-title":"Drug Alcohol Depend"},{"key":"4876_CR47","unstructured":"The Commonwealth Fund. International Health Care System Profiles: England. 2020. https:\/\/www.commonwealthfund.org\/international-health-policy-center\/countries\/england. Accessed 29 May 2025."},{"key":"4876_CR48","unstructured":"Government of Canada. About Canada\u2019s health care system. 2016. https:\/\/www.canada.ca\/en\/health-canada\/services\/canada-health-care-system.html. Accessed 29 May 2025."},{"key":"4876_CR49","unstructured":"The Commonwealth Fund. International health care system profiles: United States. 2020. https:\/\/www.commonwealthfund.org\/international-health-policy-center\/countries\/united-states. Accessed 29 May 2025."},{"key":"4876_CR50","unstructured":"Betts A. Providence Officials Approve Overdose Prevention Center. The New York Times. 2024."},{"key":"4876_CR51","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/abm\/kaac037","volume":"57","author":"CI Chilala","year":"2023","unstructured":"Chilala CI, Kassavou A, Sutton S. Evaluating the effectiveness of remote behavioral interventions facilitated by health care providers at improving medication adherence in cardiometabolic conditions: a systematic review and meta-analysis. Ann Behav Med. 2023;57:99\u2013110. https:\/\/doi.org\/10.1093\/abm\/kaac037.","journal-title":"Ann Behav Med"},{"key":"4876_CR52","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/tbm\/ibaa020","volume":"10","author":"M Nili","year":"2020","unstructured":"Nili M, Mohamed R, Kelly KM. A systematic review of interventions using health behavioral theories to improve medication adherence among patients with hypertension. Transl Behav Med. 2020;10:1177\u201386. https:\/\/doi.org\/10.1093\/tbm\/ibaa020.","journal-title":"Translational Behav Med"},{"key":"4876_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12954-018-0263-5","volume":"15","author":"KB Biello","year":"2018","unstructured":"Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, Childs E, Drainoni ML. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15:55. https:\/\/doi.org\/10.1186\/s12954-018-0263-5.","journal-title":"Harm Reduct J"},{"key":"4876_CR54","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1007\/s10461-020-02783-8","volume":"24","author":"J Velloza","year":"2020","unstructured":"Velloza J, Heffron R, Amico KR, Rowhani-Rahbar A, Hughes JP, Li M, Dye BJ, Celum C, Bekker L-G, Grant RM, Team H 067\/ADAPT S. The effect of depression on adherence to HIV pre-exposure prophylaxis among high-risk South African women in HPTN 067\/ADAPT. AIDS Behav. 2020;24:2178. https:\/\/doi.org\/10.1007\/s10461-020-02783-8.","journal-title":"AIDS Behav"},{"key":"4876_CR55","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.psc.2010.04.012","volume":"33","author":"RK McHugh","year":"2010","unstructured":"McHugh RK, Hearon BA, Otto MW. Cognitive-behavioral therapy for substance use disorders. Psychiatr Clin N Am. 2010;33:511. https:\/\/doi.org\/10.1016\/j.psc.2010.04.012.","journal-title":"Psychiatr Clin North Am"},{"key":"4876_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13643-018-0759-9","volume":"7","author":"L Knight","year":"2018","unstructured":"Knight L, Mukumbang FC, Schatz E. Behavioral and cognitive interventions to improve treatment adherence and access to HIV care among older adults in sub-Saharan Africa: an updated systematic review. Syst Rev. 2018;7:114. https:\/\/doi.org\/10.1186\/s13643-018-0759-9.","journal-title":"Syst Reviews"},{"key":"4876_CR57","doi-asserted-by":"publisher","first-page":"109229","DOI":"10.1016\/j.drugalcdep.2021.109229","volume":"231","author":"S Glasner","year":"2022","unstructured":"Glasner S, Patrick K, Ybarra M, Reback CJ, Ang A, Kalichman S, Bachrach K, Garneau HC, Venegas A, Rawson RA. Promising outcomes from a cognitive behavioral therapy text-messaging intervention targeting drug use, antiretroviral therapy adherence, and HIV risk behaviors among adults living with HIV and substance use disorders. Drug Alcohol Depend. 2022;231:109229. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.109229.","journal-title":"Drug Alcohol Depend"},{"key":"4876_CR58","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1097\/OLQ.0000000000001622","volume":"49","author":"S Qasmieh","year":"2022","unstructured":"Qasmieh S, Nash D, Gandhi M, Rozen E, Okochi H, Goldstein H, Herold BC, Jamison K, Pathela P. Self-reported use of HIV preexposure prophylaxis is highly accurate among sexual health clinic patients in New York City. Sex Transm Dis. 2022;49:790. https:\/\/doi.org\/10.1097\/OLQ.0000000000001622.","journal-title":"Sex Transm Dis"},{"key":"4876_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.3389\/fphar.2019.00721","volume":"10","author":"J Blumenthal","year":"2019","unstructured":"Blumenthal J, Pasipanodya EC, Jain S, Sun S, Ellorin E, Morris S, Moore DJ. Comparing self-report pre-exposure prophylaxis adherence questions to pharmacologic measures of recent and cumulative pre-exposure prophylaxis exposure. Front Pharmacol. 2019;10:721. https:\/\/doi.org\/10.3389\/fphar.2019.00721.","journal-title":"Front Pharmacol"},{"key":"4876_CR60","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s10461-017-1951-y","volume":"22","author":"A Abaasa","year":"2017","unstructured":"Abaasa A, Hendrix C, Gandhi M, Anderson P, Kamali A, Kibengo F, Sanders EJ, Mutua G, Bumpus NN, Priddy F, Haberer JE. Utility of different adherence measures for prep: patterns and incremental value. AIDS Behav. 2017;22:1165. https:\/\/doi.org\/10.1007\/s10461-017-1951-y.","journal-title":"AIDS Behav"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-025-04876-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-025-04876-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:06:00Z","timestamp":1771945560000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-025-04876-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4876"],"URL":"https:\/\/doi.org\/10.1007\/s10461-025-04876-8","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"18 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}